nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-EF23D6B9·Framework v5.13·Pipeline v0.4·Evaluated 13 Nov 2026·OECD: 3.1 Basic medicine·Subfield: Obstetrics and Gynecology·Basis: Full text·Type: Narrative review

Placental physioxia is based on spatial and temporal variations of placental oxygenation throughout pregnancy

Berthold HuppertzBerthold Huppertz·2023·Journal of Reproductive Immunology·10.1016/j.jri.2023.103985 ↗

Primary claim

In early-onset preeclampsia cases, all in vivo data available today point to increased oxygen values in the intervillous space of the placenta.

Tentative · intervillous oxygenation is extrapolated from uterine-vein measurements using an unvalidated healthy-term ratio
In brief

A compartment-based synthesis maps placental oxygenation across pregnancy, but its preeclampsia hyperoxia thesis depends on an unvalidated conversion from uterine-vein measurements.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Abstract

For obvious reasons, in vivo measurements of placental oxygenation are extremely rare and hence, scientists need to focus on the few studies that revealed at least some data on the topic. The scarcity of real in vivo data resulted in the development of hypotheses on placental oxygenation that blocked an objective view on the topic for decades. Only now, new hypotheses are emerging adding new views and ideas on the topic. Especially in the field of preeclampsia, hypotheses on placental oxygenation have mislead a whole generation of scientists. This review article displays the available in vivo placental oxygen data from 8 to 40 weeks of gestation. It also compares these physiological oxygen concentrations, called physioxia, with the situation in pre-placental hypoxia, i.e. pregnancies at high altitude. Finally, it summarizes what we know today about oxygen measurements in cases with preeclampsia. In early-onset preeclampsia cases, all in vivo data available today point to increased oxygen values in the intervillous space of the placenta. This is due to a reduced oxygen transfer of the placental barrier from maternal to fetal blood, resulting in hypoxia of fetal blood and the fetus.

Key Claims

Primary finding · Tentative

In early-onset preeclampsia cases, all in vivo data available today point to increased oxygen values in the intervillous space of the placenta.

intervillous oxygenation is extrapolated from uterine-vein measurements using an unvalidated healthy-term ratio

Abstract
Quote verified
Secondary · Supported

Placental physioxia is not related to a single oxygen level, but rather changes throughout pregnancy

measurements across gestation support temporal variation despite sparse coverage and heterogeneous methods

Section 8; Fig. 3A
Quote verified
Secondary · Supported

Early onset cases suffering from preeclampsia and fetal growth restriction are associated with a reduced transfer of oxygen from maternal to fetal blood, resulting in lower pO2 levels in fetal blood

compiled umbilical measurements support reduced fetal oxygenation, although the transfer mechanism remains partly inferential

Section 8; Section 6; Fig. 4B
Quote verified
Secondary · Tentative

Placental hypoxia (as in pregnancies at high altitude) is not associated with fetal hypoxia (Fig. 5D).

a single term altitude comparison cannot establish the general absence of fetal hypoxia

Section 8; Section 5.3; Fig. 5D
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Gestational synthesis extends beyond late pregnancy

The review brings measurements from early pregnancy through term into a common physiological account, making temporal changes in placental oxygenation easier to compare.

↳ Introduction; Sections 4–5; Fig. 3A

#reporting

Figures distinguish maternal and fetal compartments

The diagrams separate intervillous, uterine venous, and umbilical oxygenation rather than treating placental oxygen as a single quantity.

↳ Sections 5–7; Figs. 2–5

#methodological rigour

Discordant measurements are identified rather than hidden

Section 5.1 explicitly identifies the unusually high Soothill values and cautions against direct comparison with other studies.

↳ Section 5.1; Fig. 3B

Limitations

#methodological rigour

Pathological hyperoxia depends on unvalidated conversion

The estimated intervillous values of 33.7 and 42.6 mmHg come from uterine-vein measurements divided by a healthy-term ratio. The proposed pathological shunting mechanism means that a higher venous value need not establish higher intervillous oxygenation.

↳ Sections 5.1 and 6; Fig. 3A

#positioning

Debate is closed without resolving competing evidence

The review dismisses the hypoxia interpretation without engaging the competing molecular, histological, or imaging evidence. Its recommendation to abandon placental hypoxia/ischemia also overlooks what maternal-space estimates cannot establish about tissue oxygenation and perfusion.

↳ Abstract; Sections 6 and 8

#methodological rigour

Source selection lacks a reproducible account

Claims about all available in vivo evidence are not accompanied by search procedures or inclusion criteria. The illustrative PubMed count does not establish how studies entered the synthesis.

↳ Abstract; Section 6

Does this match your read? Add your assessment ↓

Nabu Commentary

The review's main contribution is its gestational and compartment-based organization of a sparse measurement literature. Its central preeclampsia inference is less secure: the healthy-term vein-to-intervillous conversion is not validated for the pathological shunting described in Section 6. The rejection of placental hypoxia/ischemia also goes beyond what maternal-space estimates establish about tissue oxygenation and perfusion, while competing evidence receives insufficient engagement. Clear figures aid interpretation, but neither accessible presentation nor the physiological compilation resolves these inferential limitations.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.4±0.2

Contribution
3.1

The review integrates oxygen measurements across gestation and distinguishes maternal from fetal oxygenation, extending the late-pregnancy focus of prior synthesis. Its contribution remains an interpretive map rather than a resolution of the pathological oxygenation question.

Introduction; Sections 4–7; Figs. 2–5
Methodological Rigour
1.9

The pathological intervillous estimate relies on a healthy-term conversion whose assumptions are undermined by the proposed shunting mechanism. One-sided treatment of competing evidence and unreported source selection further constrain the empirical synthesis.

Sections 5.1 and 6; Figs. 3A and 5
Reporting
3.4

The progression through gestation and the compartment-labelled figures make the physiological comparisons accessible. The altitude conclusion nevertheless communicates a broader absence of fetal hypoxia than its single cited comparison establishes.

Sections 4–8; Figs. 2–5
Positioning
2.0

The review engages the historical measurement literature but portrays the preeclampsia oxygenation debate as settled. Its categorical terminology recommendation does not account for the distinction between maternal-space oxygenation and placental tissue oxygenation or perfusion.

Abstract; Sections 5–6 and 8

Reliability

Caveats4 of 4 checks


Results checkClean

The reported numbers and statistics are consistent with the stated results.

Reporting and transparencyNoted

The text citation and reference list spell one cited surname differently. Competing interests are declared, and no substantive conduct concern is established.

Conflict of interest: declared

Reference IntegrityNoted

50 references in manuscript 48 of 50 checkable references found in an index 2 mistyped DOIs matched to the cited work by its details

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 13 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Reproductive health and childbirth · Maternal disorders
Type of advanceSynthesis
Route to useNot stated
AdvanceAdvances
BeneficiariesLarge
CitationsFWCI 1.7
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessPiloted
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The intervillous hyperoxia claim rests on a single small in vivo cohort, with intervillous values inferred indirectly from uterine vein data via a fixed ratio, and lacks independent confirmation.

The paper states only that its synthesis should clarify placental oxygen levels and may help identify the real etiology of preeclampsia, which is further research rather than a real-world use.

Pathway

Placental biologists and obstetric researchers would act on the hyperoxia reinterpretation, redirecting preeclampsia research toward placental barrier oxygen transfer and fetal hypoxia.

Barrier

The intervillous hyperoxia claim rests on one small indirect dataset, and direct in vivo placental oxygen measurements in preeclampsia remain extremely scarce.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia

    Olivia Nonn, Cornelius Fischer, Sabrina Geisberger, et al. · 2021 · Basic medicine

    Primary claim

    Ang IV decreases trophoblastic mitochondrial respiration and increases placental leptin via placental LNPEP.

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  2. Maternal platelets at the first trimester maternal-placental interface - Small players with great impact on placenta development

    Jacqueline Guettler, Désirée Forstner, Martin Gauster · 2021 · Basic medicine

    Primary claim

    In normal early human pregnancy, maternal platelets may contribute to placenta development by acting on both the extravillous- and the villous trophoblast compartment.

    Tentative
    Evidence Score
    3.1±0.1
    Reliability
    Caveats
  3. Molecular characteristics of established trophoblast-derived cell lines

    Jana Pastuschek, Olivia Nonn, Ruby N Gutiérrez-Samudio, et al. · 2021 · Basic medicine

    Primary claim

    In general, characteristics and markers of choriocarcinoma derived cell lines seem to be more similar to in vivo trophoblast than immortalized cell lines and thus might be regarded as more suitable models.

    Tentative
    Evidence Score
    3.2±0.1
    Reliability
    Caveats

How the rubric works →

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.